The α4ß7 blockade with vedolizumab is effective in prevention of graft vs. host disease using a xenogeneic mouse model.
Am J Hematol
; 95(2): E39-E41, 2020 02.
Article
in En
| MEDLINE
| ID: mdl-31724186
Full text:
1
Database:
MEDLINE
Main subject:
Integrin alpha4
/
Integrin beta Chains
/
Antibodies, Monoclonal, Humanized
/
Graft vs Host Disease
Limits:
Animals
/
Humans
Language:
En
Year:
2020
Type:
Article